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The cytokine leukemia inhibitory factor (LIF) modulates glial and
neuronal function in development and after peripheral nerve
injury, but little is known regarding its role in the injured adult
CNS. To further understand the biological role of LIF and its
potential mechanisms of action after CNS injury, effects of
cellularly delivered LIF on axonal growth, glial activation, and
expression of trophic factors were examined after adult mam-
malian spinal cord injury. Fibroblasts genetically modified to
produce high amounts of LIF were grafted to the injured spinal
cords of adult Fischer 344 rats. Two weeks after injury, animals
with LIF-secreting cells showed a specific and significant in-
crease in corticospinal axon growth compared with control
animals. Furthermore, expression of neurotrophin-3, but not
nerve growth factor, brain-derived neurotrophic factor, glia cell
line-derived neurotrophic factor, or ciliary neurotrophic factor,
was increased at the lesion site in LIF-grafted but not in control
subjects. No differences in astroglial and microglial/macro-
phage activation were observed. Thus, LIF can directly or indi-
rectly modulate molecular and cellular responses of the adult
CNS to injury. These findings also demonstrate that neurotro-
phic molecules can augment expression of other trophic factors
in vivo after traumatic injury in the adult CNS.
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After injury in the nervous system, a wide spectrum of cellular
and molecular responses are induced, including changes in tro-
phic factor expression. The precise functions of these growth and
differentiation factors after injury are still largely unknown, par-
ticularly within the CNS. Studies of regeneration in the periph-
eral nervous system (PNS) indicate that several factors implicated
in growth and differentiation are upregulated after injury and
during regeneration (Funakoshi et al., 1993; Kiefer et al., 1993;
Banner and Patterson, 1994). One of the factors that might be
important for successful regrowth of injured sensory and motor
axons in the PNS is leukemia inhibitory factor (LIF). Several
recent reports indicate a role for LIF in the response to nervous
system damage and during PNS regeneration in the neonatal
(Cheema et al., 1994a,b) and adult rat (Hendry et al., 1992;
Banner and Patterson, 1994; Curtis et al., 1994; Tham et al.,
1997). LIF is upregulated in Schwann cells after adult PNS injury
(Banner and Patterson, 1994; Curtis et al., 1994; Sun et al., 1994;
Kurek et al., 1996), its retrograde transport to the cell bodies of
sensory and motor neurons is increased after nerve lesions (Hen-
dry et al., 1992; Curtis et al., 1994), and this cytokine is required
for appropriate changes in neuronal gene expression after injury
(Rao et al., 1993; Sun and Zigmond, 1996). Moreover, LIF
promotes the survival and outgrowth of sensory and motor neu-
rons in vitro and after axotomy in vivo (Arakawa et al., 1990;
Martinou et al., 1992; Cheema et al., 1994a,b; Tham et al., 1997).
Recently, injury to the adult CNS has also been reported to
induce upregulation of LIF expression (Minami et al., 1991;
Banner et al., 1997). Increased amounts of LIF mRNA are
observed in the postepileptic hippocampus (Minami et al., 1991)
and in astrocytes and microglia after cortical lesions (Banner et
al., 1997). However, the functional significance of these increases
in LIF expression is unknown.
Potential clues regarding functional roles of LIF after nervous
system injury are suggested from studies of LIF-modulated prop-
erties in the developing nervous system (for review, see Patterson,
1994; Murphy et al., 1997). LIF can regulate neurotransmitter and
neuropeptide expression in sympathetic neurons (Yamamori et
al., 1989). Furthermore, LIF may influence the survival and
maintenance of spinal cord motor neurons (Martinou et al., 1992;
Richards et al., 1996; Sendtner et al., 1996) as well as dorsal root
ganglion and nodose ganglion sensory neurons (Murphy et al.,
1991, 1994; Hendry et al., 1992; Thaler et al., 1994). LIF can also
act on astrocytes, oligodendrocytes, and microglia. For example,
knockout mice lacking LIF or LIF receptors show reduced num-
bers of glial fibrillary acid protein (GFAP)-positive astrocytes and
display reduced levels of myelin basic protein (Ware et al., 1995;
Bugga et al., 1998). In vitro primary astrocyte cultures produce
and secrete LIF (Aloisi et al., 1994; Murphy et al., 1995), and LIF
can affect the differentiation of oligodendrocyte type-2 astrocyte
(O-2A) progenitor cells into astrocytes and alter oligodendrocyte
survival after trophic factor deprivation (Barres et al., 1993; Kahn
and De Vellis, 1994; Mayer et al., 1994; Gard et al., 1995;
Richards et al., 1996). In vitro LIF has also been reported to
increase expression of microglial-specific cell markers (Hagg et
al., 1993). Outside the nervous system, LIF modulates interleukin
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expression in a model of skin inflammation (Banner et al., 1998).
Taken together, these data suggest that LIF might influence
nervous system responses to injury by (1) acting directly on
neurons, (2) modifying astrocyte function (as shown recently for
CNTF) (Kahn et al., 1995; Lisovoski et al., 1997), or (3) influ-
encing inflammation, including microglial responses (Hagg et al.,
1993; Patterson et al., 1997; Banner et al., 1998). To date, how-
ever, the potential role of exogenous LIF in modulating adult
CNS responses to injury has not been investigated.
Using a cellular delivery approach, we determined whether
LIF influenced CNS responses to trauma. Effects of cellularly
delivered LIF on neurite outgrowth, glial activation, and trophic
factor expression after spinal cord injury in adult rats were
examined. Fibroblasts genetically modified to express augmented
amounts of LIF were grafted to the dorsally hemisected spinal
cord; embedded in a collagen matrix, these grafts provided both
LIF and potential “bridges” to regenerating neurites that are
specifically and focally targeted to the injury site (Tuszynski et al.,
1996; Grill et al., 1997). Previously we have reported the useful-
ness of this model in examining axonal growth responses in the
injured spinal cord to other cellularly delivered growth factors,
including nerve growth factor (NGF) and neurotrophin-3 (NT-3)
(Tuszynski et al., 1996; Grill et al., 1997). In the present study we
report that cellular sources of LIF enhance outgrowth of a
specific class of injured spinal cord axons and upregulate expres-
sion of the neurotrophin NT-3 in the spinal cord, yet they do not
alter morphological features of glial cell reactivity after injury.
MATERIALS AND METHODS
Construction of retroviral vectors. The rat LIF cDNA was amplified by
PCR using the 59 LIF primer TGTGAATTCGCCACCATGAAG-
GTCTTGGCCGCAGGGATT containing an EcoRI site and a Kozak
consensus sequence and the 39 LIF primer TGTGGATCCCTAGAAG-
GCCTGGGCCAACACACT including a BamHI site. The PCR product
was digested with EcoRI/BamHI and ligated into the retroviral vector
pLXSN. A retroviral producer cell line was established as described
using the ecotropic cell line psi-2 and the amphotropic cell line PA 317.
The LIF transgene was constitutively driven by the 59 LTR, and a
dominant selectable marker imparting neomycin resistance was ex-
pressed by the SV 40 promoter, as described previously (Tuszynski et al.,
1996; Grill et al., 1997). Primary rat fibroblasts transfected with Esche-
richia coli b-galactosidase were used as controls.
Cell culture. Primary cultures of Fischer 344 rat fibroblasts were gen-
erated as described previously (Tuszynski et al., 1996).
In vitro characterization of LIF-secreting fibroblasts. LIF gene expres-
sion in transduced primary fibroblasts was assessed by Northern blotting.
Twenty micrograms of total RNA were separated on a 1% formaldehy-
de–agarose gel, transferred to a nylon membrane, and hybridized to a
32P-labeled rat LIF cDNA fragment. After two washes in 13 SSC (150
mM NaCl, 15 mM sodium citrate) with 0.1% SDS for 1 hr each at 65°C,
blots were exposed to x-ray film.
For determination of LIF protein levels, serum-free supernatants were
collected from confluent monolayers of LIF- and b-galactosidase-
producing fibroblasts and concentrated by filter centrifugation (10,000
NMWL filter units; Millipore, Bedford, MA). Proteins were separated
on a 10% SDS-polyacrylamide gel and transferred to a polyvinylidene
difluoride membrane (Millipore). After blocking for 1 hr in 1% BSA in
TBS/0.25% Tween 20, blots were incubated overnight with a polyclonal
anti-LIF antibody (1:2000; Santa Cruz Biotechnology, Santa Cruz, CA),
followed by a secondary alkaline phosphatase-conjugated antibody (1:
5000; Life Technologies, Bethesda, MD).
Bioactivity of LIF secreted into the supernatant from transfected cells
was tested by coculturing the erythroleukemia cell line TF-1 (Kitamura
et al., 1989; Davis et al., 1993) with LIF-transfected and control-
transfected fibroblasts, respectively. In this assay, TF-1 cells show in-
creased proliferation in response to LIF. LIF-expressing cells were
seeded into 24-well plates and cocultured with TF-1 cells (4 3 10 4 cells
per well) starting 48 hr later by plating TF-1 cells into cell culture inserts
(Nunc, Naperville, IL). The number of viable TF-1 cells was counted 48
hr later using the trypan blue exclusion assay.
Experimental subjects. Female Fischer 344 rats weighing 160–200 gm
(Harlan Sprague Dawley) were housed three per cage with free access to
food and water. National Institutes of Health guidelines for laboratory
animal care and safety were strictly followed. Animals were killed 2
weeks after lesion/grafting surgery.
Lesion surgery. T7 dorsal laminectomies were performed on deeply
anesthetized rats [anesthetic mixture (2 ml/kg): ketamine 25 mg/ml,
rompun 1.3 mg/ml, and acepromazine 0.25 mg/ml], as described previ-
ously (Grill et al., 1997). Briefly, the dura was opened, the dorsal cord
midline was superficially incised, and the dorsal columns were removed
using a fine-tipped glass-pulled aspiration device. The lesion was contin-
ued ventrally until all dorsal white matter was removed and then ex-
tended slightly more ventrally to complete the hemisection in the central
cord region. Using this central lesion as a guide for the desired dorso-
ventral depth of the lesion, the lesion was extended laterally to remove
the lateral aspects of the cord. In this procedure, both dorsal halves of the
spinal cord are removed, leaving the ventral halves of the cord unaffected
by the lesion (Grill et al., 1997).
For in vivo grafting, LIF-secreting genetically modified fibroblasts (n 5
24 animals) or control fibroblasts (n 5 24 animals) were embedded in
type I collagen gels (Sigma, St. Louis, MO) as described previously
(Tuszynski et al., 1996). Briefly, primary transduced cells were harvested
by gentle trypsinization and suspended at a concentration of 2.1 3 10 6
cells/ml in 1 ml liquid collagen type I (Sigma) solution. After 24 hr
incubation at 37°C, gelatinous collagen blocks containing transduced
cells were trimmed and grafted to spinal cord lesion sites immediately
after the dorsal hemisection was performed. Overlying muscular layers
were sutured, and cutaneous layers were stapled. After the operation,
animals received manual bladder evacuation and 20,000 U/kg ampicillin
twice daily for 10 d to prevent and treat urinary tract infections. Lesion
extent was verified by observing (1) complete interruption of the main
body of the dorsal corticospinal tract anterogradely labeled with wheat
germ agglutinin-conjugated horseradish peroxidase (WGA-HRP) in-
jected into the sensorimotor cortex (see below), or (2) that the dorsal half
of the spinal cord had been completely removed as determined on serial
Nissl-stained sagittal sections in all subjects.
Anterograde labeling of the corticospinal tract projection. Two weeks
after lesion and grafting surgery, WGA-HRP (300 nl of a 4% solution)
was injected through pulled-glass micropipettes (40 mm internal diame-
ter) into each of 12 sites per hemisphere spanning the rostrocaudal extent
of the rat sensorimotor cortex using a PicoSpritzer II (General Valve,
Fairfield, NJ), as described previously (Grill et al., 1997). Labeling was
performed in eight LIF-grafted animals and in eight animals with control
grafts. Animals were transcardially perfused 48 hr later with 1% para-
formaldehyde/1.25% glutaraldehyde followed by 10% buffered sucrose.
Sections (35 mm thick) were cut in the sagittal plane. Six of every seven
sections were reacted with a modification of the tetramethyl benzidine
method (Grill et al., 1997) and quantified in a blinded manner (see
below). The remaining one of seven sections were Nissl-stained.
Quantification of corticospinal tract growth af ter injury. The density of
WGA-HRP reaction product was quantified in the gray matter under
light-field illumination at the level of the lesioned corticospinal tract and
in an adjacent field 0.8 mm distal to the most caudal aspect of the
lesioned corticospinal tract (CST). Nonspecific labeling products, includ-
ing random TMB crystals adhering to the lesion site, residual red blood
cells in the interstitial space, or any TMB crystals that were not oriented
in association with axonal profiles, were edited from digitized images
before quantification. Editing was essential to ensure that the quantified
images accurately reflected the WGA-HRP-labeled sections. The system
operator was blinded to the nature of the experimental group while
editing and all other aspects of analysis were conducted. The number of
pixels occupied by reaction product in the gray matter was quantified
using NIH Image software on a video image of each 1003 magnified
section transmitted by a high-resolution Sony CCD camera. Thresholding
values in NIH Image were chosen such that only TMB reaction product
resulted in measurable pixels on the digitized image; light nonspecific
background labeling was not detected. Contrast between reaction prod-
uct and background was maximized and held constant between all
subjects.
A fixed box size of 640 3 480 pixels was used to measure the number
of pixels containing WGA-HRP reaction product in every labeled sagittal
section of spinal cord gray matter beginning precisely at the level of the
spinal cord lesion site, at 1003 magnification. The sample box did not
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include the graft itself because WGA-HRP-labeled axons were not
detected within grafts (see Results). The sample box spanned the com-
plete dorsal-to-ventral extent of the gray matter in the sampled region.
Total labeled pixels from every measured section at the lesion site per
subject (a series of six-in-seven sections per animal through the entire
thickness of the spinal cord) were summed, and a total value per subject
was thereby generated. Measured pixels were divided by the area of the
sampled region to obtain the relative HRP labeling intensity per pixel.
Similar measurements were made for each subject 0.8 mm caudal to the
lesion site. To correct for differences in HRP labeling efficiency between
animals, the density of the labeled main CST was measured at a point 1.5
cm rostral to the lesion site in the three most intensely labeled sections in
each subject, using a box size of 640 3 300 pixels; this pixel value was
divided by the total sampled area in this region to obtain the relative
baseline WGA-HRP labeling density measurement (BLDM) value per
subject. The total labeled pixels per unit area at the lesion site and,
separately, 0.8 mm below it, were then divided by the BLDM value of that
subject. These corrected values were compared between animals to
determine a specific and direct measurement of CST growth. Although
few axons in the ventral component of the corticospinal tract were
labeled by WGA-HRP in this experiment, their numbers were also
quantified in all labeled sections.
Immunolabeling. Animals used for immunolabeling were transcardially
perfused with 100 ml cold 0.1 M PBS followed by 300 ml 4% parafor-
maldehyde in phosphate buffer. Spinal cords were removed, post-fixed
overnight in 4% paraformaldehyde, and then left for at least 2 d in
phosphate buffer containing 30% sucrose at 4°C. Sagittal sections were
cut at 35 mm intervals with a cryostat. Every seventh section was imme-
diately mounted on glass slides for Nissl staining. Remaining sections
were processed with immunocytochemical labels directed against the
following markers: neurofilament (RT97; 1:250; Boehringer Mannheim,
Indianapolis, IN) to detect general axonal growth; choline acetyltrans-
ferase (ChAT) (1:1000, Chemicon, Temecula, CA) to label motor axons;
tyrosine hydroxylase (TH) (1:5000; Eugenetech, Ridgefield Park, NJ) to
detect growth of axons directly extending from the coerulospinal tract;
serotonin (5-HT) (1:35,000; Chemicon) to label raphaespinal axons;
calcitonin gene-related peptide (CGRP) (1:8000; Chemicon) to label
primary sensory axons; GFAP (1:250; Boehringer Mannheim) to label
astrocyte soma and processes; and OX-42 (1:1000; Harlan Bioproducts,
Indianapolis, IN) to label macrophages/microglia. All immunocytochem-
ical labeling was performed using free-floating sections in the following
protocol: (1) overnight incubation in primary antibody at 4°C, (2) incu-
bation for 1 hr with biotinylated secondary antibodies (1:200; Vector
Laboratories, Burlingame, CA) at room temperature, (3) 1 hr incubation
with avidin–biotinylated peroxidase complex (1:100; Vector Elite Kit) at
room temperature, and (4) treatment for 3–15 min with 0.05% solution of
Figure 1. Characterization of LIF-expressing fibroblasts. A, Northern blot showing LIF RNA expression in LIF-transfected but not in control-
transfected cells. LIF, LIF- expressing cells; b-gal, b-galactosidase-expressing cells. B, Western blot. A band of 45 kDa is visible in LIF-transfected
(arrow) but not in control-transfected fibroblasts. The molecular weight of the marker proteins is indicated in lane 3. C, Growth of TF-1 cells is
significantly higher when cocultured with LIF-transfected fibroblasts than with control b-gal-expressing cells. p , 0.01; mean 6 SEM.
Figure 2. Integration of grafted fibroblasts into the host spinal cord. (A)
Low- and ( B) high-magnification view of Nissl-stained sagittal sections
show numerous surviving grafted fibroblasts 2 weeks after grafting that
span the dorsal hemisection lesion cavity (arrows) and provide a potential
tissue bridge for growing axons. There is excellent graft integration into
the lesion site. Arrows indicate host /graft interface. An LIF-secreting cell
graft is pictured. g, Graft; h, host. Scale bars: A, 230 mm; B, 45 mm.
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3.39 diaminobenzidine, 0.01% H2O2 , and 0.04% nickel chloride at room
temperature.
Quantification of GFAP expression. The density of GFAP labeling was
quantified in white matter and separately in gray matter, directly ventral
to the lesion site in three LIF- and three control-grafted animals. A
minimum of four sections randomly selected from the lesion site were
analyzed per animal under light-field illumination using NIH image
software and a digital camera similar to that described above for WGA-
HRP labeling. Pixel values in a fixed box size of 640 3 480 were averaged
for each animal to obtain a measurement of GFAP-labeling density per
unit area in white and gray matter, respectively.
RT-PCR. Two weeks after grafting RNA was isolated from LIF-
grafted (n 5 3) and control-grafted animals (n 5 3). Fresh spinal cord
(3–4 mm) containing the graft was excised and immediately frozen.
Acidic phenol /chloroform extraction was used to extract RNA, and 500
ng RNA were reverse-transcribed in a total volume of 20 ml according to
the manufacturer’s instructions (Boehringer Mannheim). Two microli-
ters of the first-strand synthesis were used for each PCR. The 50 ml PCR
reaction additionally contained 0.5 mg of each primer, 1.5 mM MgCl2 , 50
mM KCl, 10 mM Tris-HCl, pH 9.0, 0.1% Triton X-100, 0.2 mM dNTP, 2.5
mCi 32P-dCTP, and 2.5 U Taq-polymerase (Promega, Madison, WI).
Amplification was performed at the following temperature profile: 60 sec
at 94°, 30 sec at 60°C, 60 sec at 72°C. The number of cycles for each
primer pair (except LIF) was first determined to be in the logarithmic
phase of amplification using RNA from spinal cords of unoperated
controls to establish standards. The number of cycles used were 24 cycles
for RPL27, 27 cycles for LIF, 28 cycles for NGF, 30 cycles for NT-3, 26
cycles for ciliary neurotrophic factor (CNTF), 30 cycles for glia cell
line-derived neurotrophic factor (GDNF), and 27 cycles for brain-
derived neurotrophic factor (BDNF). Controls for PCR included omit-
ting reverse transcriptase from the first-strand synthesis and completely
omitting template from the PCR; in the case of both PCR controls, no
amplification products were visible.
Primers used were as follows: LIF: see construction of retroviral vectors;
RPL27: 59-AGAACATTGATGATGGCACC-39 and 59-ATATCCACA-
GAGTACCTTGT-39; NGF: 59-GCAGTGCCCCTGCTGAACCA-39 and
59-AAACAGCACGCGGGGTGAAC-39; BDNF: 59-GGAGCTGAG-
CGTGTGTGACA-39 and 59-CGGGACTTTCTCCAGGACT-39; NT-3:
59-TGCCATGGTTACTTCTGCCACG-39 and 59-GGATGCCACG-
Figure 3. WGA-HRP labeling of the main corticospinal tract. Dark-field (A, B) and light-field (C, D) illumination show that the labeling intensity of
the main corticospinal tract (cst) rostral to the injury site is similar in LIF-grafted (A, C) and control-grafted (B, D) animals. There is no significant
retraction of CST axons from the lesion site at this time point (2 weeks after injury and grafting). Inset in A shows the approximate mediolateral location
of the sections, indicating a relatively thin strip of central gray matter and wide strips of dorsal and ventral white matter; the red portion of inset indicates
the position of the dorsal CST. Scale bar: A, B, 172 mm; C, D, 220 mm. Host/graft interface is outlined by straight, filled arrows; the border between dorsal
white matter (dwm), gray matter ( gm), and ventral white matter (vwm) is indicated by dashed lines. g, Graft. Open arrows in A and B indicate the type
of artifacts that were edited from digitized images before quantification of WGA-HRP grain density (see Materials and Methods).
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GAGATAAGCAAG-39; CNTF: 59-CTCTGTAGCCGTTCTATCTG-39
and 59-GAGTATGTATTGCCTGATGG-39; GDNF: 59-CGGTAAGAG-
GCTTCTCGAAG-39 and 59-CGCTTGTTTATCTGGTGACC-39.
Twenty microliters of the PCR reaction product were separated on an
8% polyacrylamide gel. The gel was dried and exposed to x-ray film for
different times until the signals were visible but the silver grains on the
film were not saturated. Signals on x-ray films were quantified using the
NIH Image gel plot macro. Expression of different genes was quantified
relative to the mRNA levels of the ribosomal housekeeping control gene
RPL27.
Statistical analysis. All data were analyzed using unpaired Student’s t
test (two-tailed) at a 95% significance level. Statview software was used
to conduct statistical analysis.
RESULTS
Retroviral vectors were constructed for infection of primary rat
fibroblasts with rat LIF or a b-galactosidase reporter gene coding
sequence. The 59 long terminal repeat was used as a promoter for
transgene expression. Fibroblasts genetically modified to produce
LIF showed strong RNA expression as demonstrated by Northern
Figure 4. Enhanced growth of lesioned corticospinal tract axons in LIF-grafted animals. Nissl stains (A, B) show the relative amounts of host gray matter
and white matter in sections close to those pictured in C–F. A, LIF-grafted subject; B, control-grafted subject. dwm, Dorsal white matter; gm, gray matter;
vwm, ventral white matter. Arrows indicate host /graft (g) interface. Inset in A demonstrates that these sections are sampled from regions lateral to the
midline; thus, dorsal white matter containing the CST (red in inset) is no longer visible in these sections. WGA-HRP-labeled sections ( C–F) demonstrate
substantially augmented growth of WGA-HRP-labeled CST axons up to the host /graft interface in host gray matter ventral to the lesion site in
LIF-grafted (C, E) but not in control-grafted (D, F ) animals. The preponderance of this growth is located in the more dorsally located gray matter rather
than in ventrally located gray matter. In dark-field illumination (C, D), the borders between dorsal white matter (dvm), gray matter ( gm), and ventral
white matter (vwm) can be readily distinguished (indicated by dashed lines). Linear arrays of CST axons of the sort present in the gray matter of these
lesioned spinal cords (E, F ) are detectable only after injury; normally, CST-labeled ramifications in the gray matter exhibit numerous arborizations of
fine, varicose axons but not linear growth. Scale bars: A, B, 220 mm; C, D, 172 mm; E, F, 42 mm.
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blot (Fig. 1A). Supernatants of transfected cells contained a
protein of appropriate Mr of 45 kDa, which bound a polyclonal
anti-LIF antibody in Western blot (Fig. 1B). No LIF protein or
mRNA could be detected in primary control-transfected fibro-
blasts. The bioactivity of secreted LIF in the cell culture super-
natants was tested by co-culture with the LIF-responsive cell line
TF-1 (Kitamura et al., 1989;Davis et al., 1993). Growth of TF-1
cells was significantly higher when co-cultured with LIF-
transfected than with control-transfected fibroblasts (Fig. 1C)
( p , 0.01).
To investigate the effects of continuous localized LIF delivery
on injured axon growth in the spinal cord, LIF-secreting or
control b-galactosidase-producing cells were embedded in a col-
lagen matrix and grafted to the dorsally hemisected spinal cord
(n 5 24 LIF-secreting graft recipients and 24 control graft recip-
ients). Fibroblast grafts integrated into host tissue and showed
good survival for the 2 week period examined in this study (Fig.
2). All animals showed complete lesions as judged by interruption
of anterograde transport of WGA-HRP in the dorsal corticospi-
nal tract and lesion extension through at least half of the dorsal-
to-ventral extent of the spinal cord on Nissl-stained sections.
Of note, recipients of LIF-secreting cell grafts exhibited a
significant increase in CST growth compared with control-grafted
subjects at the level of the lesion ( p , 0.01), as determined by
quantification of CST axons anterogradely labeled with WGA-
HRP (Figs. 3–5). Nearly twice as many CST axonal processes
were detectable in LIF-grafted subjects compared with control-
grafted animals (Figs. 4, 5A). Interestingly, this increase in CST
axonal growth occurred through regions of host spinal cord gray
matter ventral to the lesion site, rather than extending through the
graft itself or through host white matter ventral to the graft site
(Fig. 4C–F). The augmented axonal labeling in the gray matter
was derived from axons extending from the main dorsal CST
rather than from fibers in the ventral white matter (Fig. 5B). This
increase in CST axon growth through host gray matter at the
lesion site in LIF-grafted subjects was also not an artifact of
heightened efficiency of WGA-HRP anterograde transport, be-
cause labeling intensity of the main CST 1.5 cm rostral to the
lesion site did not differ between LIF-grafted and control-grafted
groups (Fig. 3). The main CST in the dorsal funicular white
matter had not retracted from the lesion site at this 2 week
post-injury time point; corticospinal axonal die-back occurs only
at later time points after injury (Schnell and Schwab, 1993; R.
Grill, A. Blesch, M. Tuszynski, unpublished observations). At
this relatively short time point of 2 weeks after grafting, an
increase in CST axon growth through host gray or white matter at
a point 0.8 mm distal to the lesion site was not detected in the
LIF-grafted group compared with the control group. Few axons
in the ventral component of the corticospinal tract were labeled
by WGA-HRP, and no significant differences in the numbers of
these ventral axons were present when the LIF and control
groups were compared.
Immunolabeling was performed to determine whether other
axonal systems also responded to the presence of LIF-secreting
cell grafts. No differences in responses of neurofilament-labeled
axons, ChAT-labeled motor axons, CGRP-labeled primary sen-
sory axons, 5-HT-labeled serotonergic axons, or TH-labeled co-
erulospinal axons (Fig. 6) were observed when LIF-grafted and
control-grafted subjects were compared. Thus, responses of cor-
ticospinal axons to LIF-secreting cell grafts were specific among
the systems examined.
Given the apparent specificity of LIF-secreting cell grafts for
enhancing growth of the corticospinal projection, RT-PCR was
performed to determine whether these grafts influenced the
expression of the corticospinal axon growth factor NT-3 (Schnell
et al., 1994; Yee and O’Leary, 1996; Grill et al., 1997) or other
growth factors, including NGF, BDNF, GDNF, CNTF, and LIF
itself (Fig. 7). Host spinal cord containing the graft and the lesion
Figure 5. A, Quantification of corticospinal WGA-HRP-labeled processes in spinal cord gray matter. At the lesion site, there is a significant increase
in the number of WGA-HRP-labeled axonal processes in LIF-grafted recipients ( p , 0.01; mean 6 SEM). At this relatively brief time point, growth
is not increased in an adjacent field 0.8 mm distal to the lesion. Labeling was quantified as described in Materials and Methods. B, Extending
corticospinal tract axons originate from the lesioned dorsal CST. Dark-field photomicrograph from LIF-grafted subject demonstrates WGA-HRP-
labeled axons extending linear profiles from the dorsal lesioned corticospinal tract (lesioned cst) into the underlying gray matter ( gm) at the lesion site.
Arrows indicate individual axons. Scale bar, 34 mm.
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site at a time point 2 weeks after injury was used for RNA
isolation, and expression levels were compared between LIF-
grafted (n 5 3) and control-grafted (n 5 3) animals. The house-
keeping ribosomal gene RPL27 was used to normalize RNA
amounts among samples. NT-3 gene expression was significantly
higher in all animals that received LIF grafts compared with
controls. Approximately twofold-higher NT-3 RNA was detect-
able in LIF-treated animals than in controls. On the other hand,
expression levels of NGF, CNTF, GDNF, and BDNF were
similar in the two experimental groups. Continuous expression of
the LIF transgene over the 2 week experimental period was
evident for all sampled LIF-grafted subjects, whereas control-
grafted animals did not exhibit any detectable LIF expression. No
amplification products were present when reverse transcriptase
was omitted from the reaction, indicating that contamination of
the RNA preparation by DNA had not occurred.
To determine whether LIF-secreting cell grafts modulated host
glial or inflammatory responses, GFAP and OX-42 immunolabel-
ing were performed. GFAP immunolabeling revealed reactive
astrogliosis in both LIF-secreting and control cell grafts that did
not differ qualitatively at the lesion/graft site in the two groups
(Fig. 8A,B). Quantitative densitometry of GFAP immunolabeling
using NIH Image also failed to reveal significant differences
between LIF- and control-grafted animals adjacent to the lesion
Figure 6. Responses of other axonal systems to LIF-secreting and control grafts. Augmentation in the growth of other axonal systems is not observed
in LIF-grafted recipients, indicating specificity of the growth effect to corticospinal systems. Neurofilament labeling (NF ) shows no difference in overall
axonal penetration into LIF-secreting ( A) and control ( B) grafts. Neurites that do penetrate grafts are mainly of sensory origin and exhibit
immunolabeling for CGRP (C, LIF-secreting graft; D, control graft). There is also no difference in penetration of TH-labeled coerulospinal axons
adjacent to and within grafts (E, LIF-secreting; F, control grafts). Similarly, serotonergic and cholinergic axons penetrate grafts to a modest extent that
does not significantly differ between graft types (data not shown). Arrows indicate host (h)/graft (g) interface. Scale bar: A, B, 55 mm; C–F, 42 mm.
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in either white matter or gray matter (white matter: LIF-grafted:
134,650 6 10,243 pixels, control-grafted: 127,652 6 17,786 pixels,
p 5 0.735; gray matter: LIF-grafted: 165,970 6 12,041 pixels,
control-grafted: 168,964 6 2,466 pixels, p 5 0.861; values are 6
SEM). Relatively few GFAP-labeled glial processes extended
into either LIF-secreting or control cell grafts. Immunolabeling
for the microglial /macrophage marker OX-42 showed many acti-
vated microglia and macrophages in the vicinity of both LIF-
secreting and control grafts (Fig. 8). Microglial /macrophage ac-
cumulation was present at the host /graft interface, and several
OX-42-labeled cells infiltrated both grafts, but differences in the
distribution and intensity of OX-42 immunolabeling were not
appreciable at a qualitative level when comparing control and
LIF-secreting graft recipients within the graft, at the host-graft
interface, or in the host spinal cord adjacent to and distant from
the injury site. These findings do not exclude the possibility that
more subtle differences could be detected by detailed
quantification.
DISCUSSION
The present study demonstrates that the cellular delivery of LIF
to the injured adult CNS promotes corticospinal axon growth and
increases expression of another growth factor, NT-3. This is the
first in vivo demonstration that LIF can modulate responses of the
adult CNS to injury and that one neurotrophic factor can influ-
ence expression of another after adult CNS trauma. Neurotrophic
factors exert broad effects at multiple regulatory levels on cellular
function in the adult CNS, including effects on neuronal survival,
differentiation, axonal outgrowth, neurotransmitter release, and
synaptic efficacy (Eide et al., 1993; Korsching, 1993; Thoenen,
1995; Lewin and Barde, 1996). The present findings support
another role of trophic factors in the nervous system: they may
regulate nervous system function and response to injury by aug-
menting the production of other trophic factors. This is particu-
larly interesting when considered in the context of trophic factors
that lack secretory signals and may be released from cells at times
of injury, including the cytokine growth factor CNTF (a member
of the same family as LIF), and fibroblast growth factor-1, which
induces NGF expression after cortical infarction (Figueiredo et
al., 1995). Such factors could trigger a cascade of secondary
neurotrophic factor expression, thereby influencing neural cells
that are not directly targeted by the first growth factor. Neuro-
trophic factor-induced changes in the production of other neuro-
trophins have also been reported in vitro using PC-12 cells and
hippocampal cultures (Cannosa et al., 1997), in the PNS in dorsal
root ganglia (Apfel et al., 1996), and in the rat hippocampus in
vivo (Lindholm et al., 1994). Taken together with the present
study, results from experiments examining effects of exogenously
administered trophic factors must be interpreted with caution
because some effects could result indirectly from augmentation of
production of other growth factors. The further investigation of
influences on trophic factor expression by cytokines and trophic
factors will provide insight into the complex regulation and in-
teraction of trophic molecules.
The enhanced growth of corticospinal axons observed in the
present experiment may have resulted directly from LIF augmen-
tation of injured corticospinal axon growth or indirectly from
LIF-modulated increases in NT-3 expression. Previous findings
support a potential direct role for LIF action on corticospinal
axons. (1) CNTF receptors, which mediate signal transduction
using the same receptor components as LIF (plus the additional
CNTF binding component CNTF receptor a), are present on
cortical layer V neurons (Ip et al., 1993a). CNTF-responsive
neuronal populations generally display identical responses to LIF
(Martinou et al., 1992; Rao et al., 1992; Fann and Patterson, 1993,
1994). (2) CNTF promotes corticospinal motoneuron survival in
vitro (Magal et al., 1993). CNTF has also been reported to protect
corticospinal motor neurons from intracortical axotomy (Dale et
al., 1995), although the latter study did not determine whether
CNTF might have modulated expression of other neurotrophins
such as NT-3 that also act on corticospinal axons. On the other
hand, LIF could also have indirectly influenced corticospinal
axonal growth in the present experiment, because LIF-secreting
cell grafts upregulated NT-3 expression, and NT-3 is a cortico-
spinal axon growth factor (Schnell et al., 1994; Yee and O’Leary,
1996). We have previously reported that the cellular delivery of
NT-3 to the lesioned spinal cord augments corticospinal axonal
growth (Grill et al., 1997), suggesting that the present findings
could have resulted from augmented NT-3 release at the injury
site.
The effects of cellular LIF delivery on corticospinal axons have
been referred to in this report as enhanced “growth.” This
generic term is used to reflect the possibility that either axonal
regeneration (i.e., growth from the tips of injured axons), sprouting
Figure 7. LIF-secreting cells augment NT-3 gene expression in vivo. A,
Semiquantitative RT-PCR demonstrates clearly upregulated NT-3 ex-
pression in all LIF-grafted animals compared with control-grafted ani-
mals. No differences in NGF, BDNF, CNTF, and GDNF expression exist
between LIF and control grafts (NGF expression is slightly but not
significantly higher). Continued LIF transgene expression is evident in all
LIF-grafted animals through the experimental period (2 weeks). B, Mea-
surement of neurotrophin signal intensity shows significantly higher ex-
pression of NT-3 in LIF-grafted compared with control-grafted animals
( p , 0.05 for NT-3; mean 6 SEM). Units for NT-3 expression levels are
provided as the ratio of NT-3 to RPL 27 expression, as a means of
controlling for small differences in RNA amounts that may be present.
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(i.e., growth from neighboring, uninjured axons), or both may
have occurred. Evidence for the presence of regeneration in this
paradigm is provided in Figure 5B, wherein axonal extension
directly from transected tips of corticospinal axons is shown.
Axonal sprouting also occurs and is evident in Figure 4C: en-
hanced CST labeling is observed in gray matter ventral and
slightly rostral to the injury site. Either or both of these mecha-
nisms may have contributed to the increased density of CST
axons at the lesion site in LIF-grafted subjects, where axonal
density measurements were made (Figs. 4E,F, 5A).
In the present experiment, corticospinal axons were unable to
penetrate the collagen graft despite the presence of a growth-
promoting stimulus provided by the LIF-secreting fibroblasts.
This finding is similar to our observations that grafts of NT-3-
producing fibroblasts to the injured spinal cord elicit CST axonal
growth in spinal gray matter rather than in white matter or into
the graft itself (Grill et al., 1997). This lack of axonal penetration
might be caused by inhibitory molecules expressed at the host /
graft interface or by the nonpermissiveness of the extracellular
milieu in the graft environment, which contains abundant
amounts of fibronectin and collagen. Although CST axons are
unable to penetrate a cellular graft producing growth-promoting
trophic molecules, other populations of axons successfully pene-
trate these grafts (Fig. 6) and specifically associate with extracel-
lular molecules of the graft (Tuszynski et al., 1996). For example,
sensory axons robustly penetrate grafts of fibroblasts transduced
to express NGF, and associate with collagen within the grafts
(Tuszynski et al., 1996). Sensory axons also penetrated LIF-
secreting grafts in the present experiment, but not to an extent
that differed significantly from control grafts. Thus, the extent and
direction of axonal growth after adult CNS injury appears to be
determined both by growth factor gradients and by the nature of
the local extracellular matrix.
Further indirect mechanisms for LIF-induced modulation of
CNS axonal growth are possible through alteration of glial or
inflammatory responses after injury. In the present experiment,
an effect of cellular LIF delivery on astrocytic responses was not
detected at qualitative or quantitative levels, nor were qualitative
changes in OX-42 labeling of macrophages/microglia detected.
These in vivo results confirm a recent report that LIF does not
enhance proliferation of microglia cultivated on an astrocyte
monolayer in vitro (Kloss et al., 1997). However, as mentioned in
the introductory remarks, findings from LIF- and LIF-receptor-
knockout mice indicate that LIF regulates GFAP expression in
the CNS (Ware et al., 1995; Bugga et al., 1998). CNTF, another
member of the cytokine family of growth factors, also modulates
astrogliosis and microglial proliferation (Ip et al., 1993b; Kahn et
al., 1995; Lisovoski et al., 1997). Because the spinal cord injury
upregulated GFAP immunoreactivity in the present experiment,
it is possible that an effect of LIF delivery that exceeded the
Figure 8. Microglial and astroglial activation at the host /graft interface. A, B, GFAP-immunolabeled processes are present at the host ( h)/graft (g)
interface, but extend relatively few processes into the graft. Qualitative and quantitative differences in GFAP labeling are not evident when comparing
LIF-secreting (A) and control (B) grafts. Macrophages/microglia surround and invade (C) LIF-secreting and (D) control grafts to a similar extent, as
shown by OX-42 labeling. Scale bar, 55 mm.
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robust stimulus of the spinal cord injury itself was not detectable.
LIF delivery could also enhance or inhibit the inflammatory
activity of macrophages or neutrophils (Ulich et al., 1994; Patter-
son et al., 1997; Banner et al., 1998), which may influence axonal
growth after injury. Although qualitative analysis failed to yield
evidence of LIF-induced changes in a macrophage/microglia
marker in the present experiment, subtle differences might have
been below the threshold of detectability with the techniques
used, and effects on other components of the inflammatory re-
sponse have not been excluded. The fact that only female rats
were used in this study could also influence these results, because
inflammatory responses can vary between sexes. Although the
present findings have not provided direct evidence of a role for
cellular LIF delivery in modulating glial responses in the injured
adult CNS, it is possible that glia were the source of augmented
NT-3 expression detected in recipients of LIF-secreting grafts.
In summary, results from this study support a role for LIF in
modulating responses of the CNS to injury. LIF can increase
neurotrophic factor expression and promote the growth of a
specific class of injured axons in the CNS. The interplay of
overlapping and distinct actions of classic neurotrophic factors
and cytokine growth factors collectively appear to determine cell
fate, axonal growth, glial activation, and inflammatory responses
to injury. The experimental manipulation of these factors, as
demonstrated in this and other experiments, can provide a means
of enhancing the degree of CNS recovery from injury.
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